These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24579465)

  • 21. [Comparison of quantitative hepatitis B virus DNA levels in serum and liver biopsy samples of chronic hepatitis B patients].
    Rüzgar M; Cetin Akhan S; Vahaboğlu H
    Mikrobiyol Bul; 2008 Apr; 42(2):283-91. PubMed ID: 18697426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C.
    Falasca K; Ucciferri C; Dalessandro M; Zingariello P; Mancino P; Petrarca C; Pizzigallo E; Conti P; Vecchiet J
    Ann Clin Lab Sci; 2006; 36(2):144-50. PubMed ID: 16682509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Identification of factors associated with YMDD mutation in patients with chronic hepatitis B receiving lamivudine treatment].
    Cao XX; Li J; Qiu LM; Luo YW; Chen YH; Ran Y
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):641-4. PubMed ID: 19785947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of TLR1-10 expression in peripheral blood mononuclear cells with chronic hepatitis B and chronic hepatitis B-related liver failure.
    Wang K; Liu H; He Y; Chen T; Yang Y; Niu Y; Chen H; Chen Y; Liu J; Ye F; Lin S; Zhao Y
    Hum Immunol; 2010 Oct; 71(10):950-6. PubMed ID: 20667457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B].
    Lu H; Ma LX; Xu WS; Zhang HY; Yu LJ; Duan HY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):173-5. PubMed ID: 12681068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased interleukin-32 expression in chronic hepatitis B virus-infected liver.
    Xu Q; Pan X; Shu X; Cao H; Li X; Zhang K; Lu J; Zou Y; Li X; Liu H; Zhang Y; Yang D; Ning Q; Shen G; Li G
    J Infect; 2012 Oct; 65(4):336-42. PubMed ID: 22687868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B].
    Kim KH; Na IH; Cha JM; Cho YK; Park SY; Kim HP; Song CS; Heo J; Cho M
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):284-92. PubMed ID: 14695695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-34 inhibits hepatitis B virus replication in vitro and in vivo.
    Cheng ST; Tang H; Ren JH; Chen X; Huang AL; Chen J
    PLoS One; 2017; 12(6):e0179605. PubMed ID: 28614380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B7-H1 expression is upregulated in peripheral blood CD14+ monocytes of patients with chronic hepatitis B virus infection, which correlates with higher serum IL-10 levels.
    Geng L; Jiang G; Fang Y; Dong S; Xie H; Chen Y; Shen M; Zheng S
    J Viral Hepat; 2006 Nov; 13(11):725-33. PubMed ID: 17052271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between intrahepatic hepatitis B virus cccDNA levels and other activity markers in patients with HBeAg-negative chronic hepatitis B infection.
    Guner R; Karahocagil M; Buyukberber M; Kandemir O; Ural O; Usluer G; Inan D; Koksal I; Baykam N; Hizel K; Yamazhan T; Esen S; Tasyaran MA
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1185-91. PubMed ID: 21934508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between serum HBV DNA level and HBV-specific, nonspecific cytotoxic T lymphocytes and natural killer cells in patients with chronic hepatitis B.
    Gu XB; Yang XJ; Wang D; Hua Z; Xu YQ; Lu ZH
    Chin Med J (Engl); 2009 Sep; 122(18):2129-32. PubMed ID: 19781297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hepatopathy and hepatitis B virus infection in dialysis patients: cross-sectional study].
    Fabrizi F; Bisegna S; Mangano S; Alongi G; Colucci P; Finazzi S; De Vecchi AF; Ponticelli C
    G Ital Nefrol; 2002; 19(2):149-54. PubMed ID: 12195413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dynamics of serum HBV DNA levels during the terminal phases of acute-on-chronic hepatitis B liver failure with different HBeAg status].
    Lai J; Gan WQ; Xie DY; Zhang K; Ke WM; Gao ZL
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jul; 20(7):522-5. PubMed ID: 23044238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum soluble death receptor 5 concentration in patients with chronic hepatitis B is associated with liver damage and viral antigen level.
    Du J; Wang L; Han J; Gao L; Ma C; Liang X
    Clin Biochem; 2012 Jul; 45(10-11):845-7. PubMed ID: 22537456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
    Papatheodoridis GV; Manesis EK; Manolakopoulos S; Elefsiniotis IS; Goulis J; Giannousis J; Bilalis A; Kafiri G; Tzourmakliotis D; Archimandritis AJ
    Hepatology; 2008 Nov; 48(5):1451-9. PubMed ID: 18924246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in circulating MMP-9 levels with regard to viral load and AST:ALT ratio between chronic hepatitis B and C patients.
    Helaly GF
    Br J Biomed Sci; 2011; 68(1):38-42. PubMed ID: 21473261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increasing hepatitis B viral load is associated with risk of significant liver fibrosis in HBeAg-negative but not HBeAg-positive chronic hepatitis B.
    Croagh CM; Bell SJ; Slavin J; Kong YX; Chen RY; Locarnini S; Desmond PV
    Liver Int; 2010 Sep; 30(8):1115-22. PubMed ID: 20492511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients.
    Wu W; Li J; Chen F; Zhu H; Peng G; Chen Z
    J Gastroenterol Hepatol; 2010 Apr; 25(4):750-7. PubMed ID: 20492330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study of genotype B and C hepatitis B virus-induced chronic hepatitis in relation to the basic core promoter and precore mutations.
    Watanabe K; Takahashi T; Takahashi S; Okoshi S; Ichida T; Aoyagi Y
    J Gastroenterol Hepatol; 2005 Mar; 20(3):441-9. PubMed ID: 15740490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characteristic of liver pathology in HBeAg-positive and HBeAg-negative chronic hepatitis B patients with mildly elevated ALT].
    Liu SQ; Zhu XJ; Sun XH; Li M; Gao YQ
    Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):348-52. PubMed ID: 22971279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.